One million patients in the United States suffer from angina: chest pain due to blockage of the arteries in the heart. Thirty-three percent of these patients are not afforded any benefit from traditional therapy such bypass surgery, oral medications or insertion of stents in the blocked vessels.
Adult, autologous stem cell therapy has recently been demonstrated to be of benefit to these patients. At Northwest University, 167 patients with severe angina underwent a prospective, randomized study in which autologous, adult stem cells were injected into the heart muscle. Six months after the procedure, those patients who had received autologous stem cell therapy had significantly improved exercise tolerance. These are the same patients who were not candidates for conventional therapy.
If you are a patient and disagree with their proposed restriction of your healthcare, please visit: www.safestemcells.org.